Pro-Pharmaceuticals, Inc. Reports First Quarter Results

NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of first-in-class, carbohydrate-based targeted therapeutic compounds to treat cancer and liver fibrosis, today reported its financial results for the first quarter of fiscal 2008. These results are included in the Company’s Quarterly Report on Form 10-Q for the three-month period ended March 31, 2008, which has been filed with the SEC.

MORE ON THIS TOPIC